Down-regulation of C-terminal binding protein 2 (CtBP2) inhibits proliferation, migration, and invasion of human SHSY5Y cells in vitro

Neurosci Lett. 2017 Apr 24:647:104-109. doi: 10.1016/j.neulet.2017.02.006. Epub 2017 Feb 6.

Abstract

Neuroblastoma is the most common extracranial solid tumor in children and is responsible for ∼15% of pediatric cancer deaths. CtBP2 is a member of the CtBP family of proteins that functions as a transcription regulator and has been demonstrated to interact with the C-terminus of the adenoviral E1A oncoprotein. In this study, the expression of CtBP2 in the human neuroblastoma cell line SHSY5Y was down-regulated using lentiviral-mediated RNA interference. Down-regulation of CtBP2 inhibited the expression of c-myc, MMP2, and MMP9 proteins. Moreover, low expression of CtBP2 resulted in inhibited cell growth, proliferation, migration, and invasion, and the cell cycle was arrested at G2/M-phase. These results indicate that CtBP2 may be a potential target to suppress tumorigenesis in neuroblastoma.

Keywords: CtBP2; Neuroblastoma; Proliferation; SHSY5Y; c-myc.

MeSH terms

  • Alcohol Oxidoreductases / genetics
  • Alcohol Oxidoreductases / metabolism*
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Co-Repressor Proteins
  • Down-Regulation
  • G2 Phase Cell Cycle Checkpoints
  • Humans
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Neoplasm Invasiveness
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Neuroblastoma
  • Proto-Oncogene Proteins c-myc / metabolism
  • RNA Interference

Substances

  • Co-Repressor Proteins
  • Nerve Tissue Proteins
  • Proto-Oncogene Proteins c-myc
  • Alcohol Oxidoreductases
  • CTBP2 protein, human
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9